Blue Water Acquisition Corp. III

Blue Water Acquisition Corp. III (the "Company") is a blank check company incorporated on November 1, 2024, as a Cayman Islands exempted company, with no material operations of its own ¹. The Company was formed for the purpose of effecting a Business Combination with one or more businesses, with an expected focus on biotechnology, healthcare, and technology companies ². As of December 31, 2025, the Company has not commenced any operations, and all activities relate to its formation, the Initial Public Offering (IPO), and identifying and negotiating a potential Business Combination ³. The Company will not generate operating revenues until after the completion of its initial Business Combination ⁴. Non-operating income is generated from interest income on cash and cash equivalents and dividend income from marketable securities derived from the IPO proceeds ⁵.

The core business model of Blue Water Acquisition Corp. III is to identify and acquire a target business through a Business Combination, rather than operating a business itself ⁶. The Company generates revenue in the form of non-operating income from interest and dividends on its Trust Account assets ⁷. Its primary customer segments are the public shareholders who invest in its units, Class A ordinary shares, and warrants, with the expectation of participating in a combined public company post-Business Combination ⁸. The Company offers a target business an alternative to a traditional IPO, allowing owners to exchange their equity for the Company's Class A Ordinary Shares or a combination of shares and cash ⁹.

The Company's financial activities for the year ended December 31, 2025, resulted in a net income of $4,667,721 ¹⁰. This was primarily driven by $5,796,563 of income earned on cash and marketable securities held in the Trust Account ¹¹. These gains were partially offset by various expenses, including $502,754 for formation, general, and administrative expenses ¹², $474,966 for legal and accounting expenses ¹³, $54,583 for listing fees ¹⁴, $54,398 for administrative support fees ¹⁵, and $42,141 for insurance expense ¹⁶. For the period from November 1, 2024 (inception) through December 31, 2024, the Company reported a net loss of $48,541, consisting entirely of formation, general, and administrative expenses ¹⁷. As of December 31, 2025, the Company had no cash or cash equivalents in its operating account and a working capital deficiency of $109,004 ¹⁸. Net cash used in operating activities for the year ended December 31, 2025, was $938,877 ¹⁹.

Significant operational developments during the reported period include the consummation of the Initial Public Offering on June 11, 2025, which involved the sale of 25,300,000 units at $10.00 per unit, generating gross proceeds of $253,000,000 ²⁰. This included the full exercise of the underwriters' over-allotment option for 3,300,000 units ²¹. Simultaneously, 683,000 Private Placement Units were sold at $10.00 per unit to the Prior Sponsor and BTIG, LLC, generating gross proceeds of $6,830,000 ²². Following the IPO, $253,000,000 from the net proceeds was placed in a Trust Account ²³. On November 25, 2025, a Purchase Agreement was executed where Yorkville BW Acquisition Sponsor, LLC (the "New Sponsor") acquired 6,325,000 Class B Ordinary Shares and 430,000 Private Placement Units from the Prior Sponsor for an aggregate purchase price of $7,200,000 ²⁴. This transaction also led to the resignation of the prior board and officers and the appointment of a new board and management team by the New Sponsor ²⁵. The Administrative Services Agreement with the Prior Sponsor was terminated on November 25, 2025, after incurring and paying $54,398 in administrative costs ²⁶.

Blue Water Acquisition Corp. III's primary objective is to complete an initial Business Combination, with a stated focus on biotechnology, healthcare, and technology companies ²⁷. The Company has a Completion Window of 24 months from the closing of its Initial Public Offering (June 11, 2025) to consummate this combination, or an earlier liquidation date as approved by its board of directors ²⁸. If the Company anticipates being unable to complete the Business Combination within this 24-month period, it may seek shareholder approval to amend its memorandum and articles of association to extend the deadline ²⁹. However, the Company does not expect to extend the time period beyond 36 months from the IPO closing ³⁰. If an initial Business Combination is not completed within the Completion Window, the Company will redeem its Public Shares at a per-share price equal to the aggregate amount in the Trust Account, including interest (net of taxes and up to $100,000 for dissolution expenses), divided by the number of outstanding Public Shares ³¹. The pro rata redemption price is expected to be approximately $10.00 per Public Share, excluding interest or other income ³².

The Company's growth strategy is entirely dependent on successfully identifying and acquiring a suitable target business ³³. It intends to capitalize on the management team's experience in financial services, transaction experience, and relationship networks to evaluate acquisition opportunities ³⁴. The Company has identified general criteria for evaluating prospective Business Combination opportunities, including opportunities for growth, financial value, technology and risk management infrastructure, a strong management team, and strength, reach, and yield opportunities ³⁵. The Company may deviate from these criteria if justified ³⁶. Management will employ various strategies to identify targets, such as contacting investment banks, brokers, and other financial community members, caucusing officers and directors for candidates, and fielding inbound inquiries ³⁷.

Regarding its operational outlook, the Company expects to incur increased expenses as a public company for legal, financial reporting, accounting, and auditing compliance, as well as for due diligence expenses ³⁸. These expenses are anticipated to increase substantially after identifying a target for its initial Business Combination ³⁹. The Company has identified a material weakness in its internal control over financial reporting related to the lack of properly designed, implemented, and effectively operating controls ⁴⁰. Management plans to implement a remediation plan, including designing and maintaining a formal control environment, accounting policies, procedures, and controls for accurate financial reporting, and enhancing processes to apply complex accounting standards, potentially utilizing third-party professionals ⁴¹.

Planned capital allocation is focused on facilitating the Business Combination. Substantially all of the net proceeds from the IPO and private placement, totaling $253,000,000, were placed in a Trust Account ⁴². These funds are to be invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting specific Investment Company Act conditions, or held in cash in an interest-bearing demand deposit account ⁴³. The Company may withdraw interest earned on Trust Account funds to pay taxes ⁴⁴. On January 26, 2026, the Company issued a convertible unsecured promissory note (Working Capital Note) in the aggregate principal amount of $500,000 to the Sponsor to provide additional working capital ⁴⁵. This note does not accrue interest and is convertible at the Sponsor's election upon Business Combination into units identical to the Private Placement Units at $10.00 per unit ⁴⁶. Up to $1,500,000 of such loans from the Sponsor may be convertible into Private Placement Units ⁴⁷.

The Company explicitly flags several structural headwinds and execution risks. Intense competition from other blank check companies, private equity groups, and operating businesses for acquisition opportunities may make it difficult to complete an initial Business Combination ⁴⁸. The Company's limited financial resources compared to competitors may disadvantage it in acquiring larger target businesses ⁴⁹. The obligation to pay cash for public shareholder redemptions may reduce available resources for the Business Combination and make the Company's financial condition unattractive to potential targets ⁵⁰. The 24-month Completion Window may give target businesses leverage in negotiations and limit due diligence time ⁵¹. The potential for a U.S. federal excise tax on redemptions if the Company domesticates to a U.S. corporation could reduce cash available to the target and make transactions less appealing ⁵².

Geopolitical and macro factors are also identified as constraints. Current global geopolitical conditions, including the ongoing Russia-Ukraine conflict, the Israel-Hamas conflict, and escalating military conflicts involving the United States, Israel, and Iran, could materially adversely affect the search for a Business Combination and any target business ⁵³. These conflicts have caused volatility in commodity prices, credit and capital markets, supply chain interruptions, and increased cyber-attacks ⁵⁴. Changes in international trade policies, tariffs, and treaties, such as the U.S. imposing new worldwide tariffs, could negatively affect the attractiveness of certain targets or lead to adverse effects on a post-Business Combination company ⁵⁵. Macro-economic turbulence, including reduced business activity, high unemployment, rising interest rates, and inflation, could adversely affect the Company's financial condition and its ability to find a commercially viable target ⁵⁶.

The Company faces material risks including the potential inability to complete an initial Business Combination within the 24-month Completion Window, which would result in the redemption of Public Shares at approximately $10.00 per share ³² and render warrants worthless ⁵⁷. Third-party claims against the Trust Account could reduce the per-share redemption amount to less than $10.00 ⁵⁸. Changes in laws or regulations, particularly the SEC's new SPAC Rules, may increase costs and time needed for a Business Combination and could lead to the Company being deemed an investment company, imposing burdensome compliance requirements or restricting activities ⁵⁹. Geopolitical instability from conflicts in Ukraine, the Middle East, and Southwest Asia, along with changes in international trade policies and tariffs, could adversely affect the search for a target and the post-combination business's performance ⁶⁰. The Company has identified a material weakness in its internal control over financial reporting due to a lack of properly designed, implemented, and effectively operating controls ⁴⁰, which could lead to material misstatements. Furthermore, the Company's independent registered public accounting firm's report expresses substantial doubt about its ability to continue as a "going concern" due to no cash in its operating account and a working capital deficiency of $109,004 as of December 31, 2025 ¹⁸, and expected significant costs in pursuit of acquisition plans ⁶¹.

Management's message emphasizes the Company's status as a blank check company formed to effect a Business Combination, with an expected focus on biotechnology, healthcare, and technology companies ². They highlight their reliance on the management team's significant experience in financial services, transaction expertise, and relationship networks to identify and acquire a suitable business ³⁴. A key strategic priority is to complete an initial Business Combination within the 24-month Completion Window from the IPO closing on June 11, 2025 ²⁸. Management acknowledges the need to address a material weakness in internal control over financial reporting and plans to implement a remediation plan to enhance financial accounting, reporting, and disclosures ⁴¹. Another strategic priority is to manage liquidity, as evidenced by the issuance of a convertible unsecured promissory note for $500,000 to the Sponsor on January 26, 2026, to provide additional working capital ⁴⁵. The Chief Executive Officer and Director, Kevin McGurn, receives a monthly advisory fee of $15,000 for services related to identifying, investigating, negotiating, and completing the initial Business Combination ⁶².